Matthew Feinsod

Insider Reports History

Location
Alachua, FL
Signature
/s/ Andrew Oxtoby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Feinsod:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Chief Medical Officer Common Stock 4,030 $40,605 $10.08 18 Mar 2025 Direct
Kalaris Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 101,000 10 Apr 2025 Direct

Insider Reports Filed by Matthew Feinsod

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KLRS Kalaris Therapeutics, Inc. 10 Apr 2025 2 $0 4 Chief Medical Officer 11 Apr 2025, 16:52
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 2 $0 4 Chief Medical Officer 18 Mar 2025, 17:43
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 0 $0 3 Chief Medical Officer 18 Mar 2025, 17:17